Osteopenia Completed Phase 2 Trials for Setrusumab (DB14778)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01406548Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral DensityTreatment